First Be(I) compounds to be crystallized could open up new main-group chemistry

Method provides petroleum-free way to turn industrial biowaste into valuable commodity

Only 13% of oxide crystal structures obey 4 of the 5 rules simultaneously

Double bonds form nitrogen-containing 3-membered rings thanks to a reactive yet fleeting oxaziridine intermediate

160-million-atom simulation reveals potential drug targets

As the founder of multiple biotech firms, C&EN's guest editor has learned a thing or two about the challenges and triumphs of starting a company. We asked her to share her best advice for budding academic entrepreneurs

Shocked to learn how little plastic gets recycled, the duo founded a company so they could make a difference

Her company, Orchestra Scientific, is developing membrane technology to separate carbon dioxide from other gases and use it as a product

Lucy Therapeutics founder is taking an atypical approach to finding drugs for central nervous system diseases

Her company, MicroByre, is proving that wild microbes can be engineered to produce useful chemicals

With Prieto Battery, the Colorado State professor has redesigned the lithium-ion battery from the bottom up

With Curie Co., the entrepreneur designs alternatives to compounds like parabens that have fallen out of favor with retailers

Barred as a woman from becoming a brewer in India, Mazumdar-Shaw instead founded biotech firm Biocon and today focuses on affordable health care

Her company, Biobot Analytics, is analyzing wastewater to give communities the information they need for the battle

Her company, Saule Technologies, has a low-cost process to print the solar cells on a multitude of materials

Her company, Esya Labs, is developing DNA nanodevices that track drug responses, screen for new therapies, and more

The MIT chemical engineering head is charting a course into the start-up world with LayerBio

Nanotech pioneer aims to pursue grand challenges rather than just write about them

Known as Big Sister for her mentorship, Du and her newest firm, Zai Lab, are setting new standards in Asia

Prolific biotech business founder says she's always on the lookout for problem-solving opportunities

Nobel Prize winner wants to solve real-world problems with directed evolution

The gene-editing tool CRISPR-Cas9 rerouted Doudna's career path. What hasn't changed for the renowned scientist and serial entrepreneur? Living and breathing the science

Dozens of women lead CRISPR-based projects worldwide. Here are a few who've built start-ups around the technology

With guest editor Jennifer Doudna, CRISPR pioneer

Gilead toma ventaja gracias a un antiviral, mientras que Moderna está buscando una nueva vacuna ARNm.

Concerns over the spread of the novel coronavirus leads to decision

Our collection of chemistry photos will help train an algorithm to recognize lab materials, vessels, and processes

C&EN looks at how scientists are adapting to travel restrictions and working from home

Spring lineup of conferences and events frequented by chemists is slashed

Hear what C&EN's pharmaceutical editors have learned about how the coronavirus is affecting drug production in China and across the globe

Creating more opportunities for dialogue is just the first step

DRT brings sustainable fragrance ingredients and industrial additives

Scientists use an alkali hydroxide–based system to turn carbon dioxide into a carbon-neutral fuel

Titanium-dioxide stars lance the skin with microscopic holes to allow medicine through

Complaint alleges trade secret theft, patent infringement on separator films

The technique, called MicroMapping, identifies potential protein interactions on and between cells

Chemical makers brace for a slowdown on the continent

Several approved and well-studied small molecules could be repurposed as treatments for COVID-19

Ammonium salts may serve as nitrogen reservoirs on the icy bodies, suggesting a common origin for comets and the sun

Microbe-specific tracers could help detect infection without relying on inflammation as a surrogate

Untargeted capture and analysis turns up previously unobserved airborne PFAS

Quantum technology, energy materials, and genomics are priorities

Agency's approach for assessing risks to endangered species relies on real-world data

The novel virus is one of the easiest virus types to deactivate, though SARS-CoV-2–specific data are lacking